Andrew C. Krakowski, MD, board certified pediatric dermatologist and faculty member of the St. Luke’s Dermatology Residency ...

Home health providers are transforming patient care by incorporating specialized home health care initiatives, from pediatric ...

HMGS Dermatology is proud to announce that four of its distinguished physicians have been named to Philadelphia Magazine's prestigious Top Doctors 2025 list in dermatology. Marlton, New ...

The FDA approved Zoryve cream 0.05% for the treatment of children aged 2 to 5 years with mild to moderate atopic dermatitis, ...

Wan specializes in pediatric dermatology and leads an active research program focused on patient-oriented investigations of ...

The experience for patients will stay the same but the change will help the practice update its technology and continue to grow.

Research highlights the need for diverse data on drug efficacy in atopic dermatitis to address barriers to treatment for ...

Children with moderate-to-severe generalized pustular psoriasis showed faster recovery, shorter hospital stays, and lower ...

YUFLYMA® (adalimumab-aaty), and its unbranded version, are now approved for two additional pediatric indications - adolescent hidradenitis suppurativa (HS) and pediatric uveitis (UV), in the ...